Glycoproteomics investment @ LUMC

The Center for Proteomics and Metabolomics of LUMC is partner of the BioBeyond_NL project which, together with Maastricht University, Utrecht University and Radboud UMC, received funding via the National Roadmap for Large-Scale Scientific Infrastructure (NWO). BioBeyond_NL provides integrated access to cutting‑edge mass spectrometry, spatial biology, and glycoscience technologies to help researchers explore biological information beyond the genetic code.
At LUMC, this initiative will strengthen our glycoproteomics mass spectrometry infrastructure, enabling new discoveries in glycoscience.

More information about the BioBeyond program can be found here:
https://www.biobeyond.nl/about/biobeyond_nl

Glycoproteomics investment @ LUMC

Groups

Proteomics

The proteomics group performs state-of-the art mass spectrometric analyses of peptides/proteins, with an historical focus on immunology, i.e. HLA-peptidomics, cell biology and microbiology.

Glycomics

Glycosylation plays important roles in immunity, development, infectious diseases and cancer.

Metabolomics

Metabolomics is defined as the systemic analysis of the metabolome, which encompasses the totality of the metabolites in a biological system, i.e., the end-points and intermediate products of metabolism

MS Imaging

Mass spectrometry imaging (MSI) is a technology that simultaneously provides the spatial distribution of hundreds of biomolecules directly from tissue.

Bioinformatics

The Bioinformatics group uses computational tools to bring together data from different domains in order to better understand human disease.

Tissue Glycomics

The Tissue Glycomics group is dedicated to study glycosylation in human tissues in health and disease.

Proteoform Profiling

Proteoforms are very diverse in structure and function. The Proteoform Profiling group focuses on developing and applying MS-based techniques to unravel the structure and function of proteoforms.

Collaborate with us